Simple jQuery Dropdowns

Browsing by Author John G. McNeil

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
31-Mar-2005Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in ThailandChitraporn Karnasuta; Robert M. Paris; Josephine H. Cox; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Arthur E. Brown; Sanjay Gurunathan; James Tartaglia; William L. Heyward; John G. McNeil; Deborah L. Birx; Mark S. De Souza; Armed Forces Research Institute of Medical Sciences, Thailand; U.S. Military HIV Research Program; Mahidol University; Sanofi Pasteur SA; Aventis Pasteur; VaxGen, Inc.
1-Sep-2007A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boostPrasert Thongcharoen; Vinai Suriyanon; Robert M. Paris; Chirasak Khamboonruang; Mark S. De Souza; Silvia Ratto-Kim; Chitraporn Karnasuta; Victoria R. Polonis; Lynn Baglyos; Raphaelle El Habib; Sanjay Gurunathan; Susan Barnett; Arthur E. Brown; Deborah L. Birx; John G. McNeil; Jerome H. Kim; Faculty of Medicine, Siriraj Hospital, Mahidol University; Chiang Mai University; Armed Forces Research Institute of Medical Sciences, Thailand; HJF; Sanofi Pasteur; Sanofi Pasteur SA; Novartis Vaccines and Diagnostics, Inc.; US Army Medical Materiel Development Activity; Centers for Disease Control and Prevention; PATH Malaria Vaccine Initiative; Mahidol University
15-May-2012The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S. De Souza; Silvia Ratto-Kim; Weerawan Chuenarom; Alexandra Schuetz; Somsak Chantakulkij; Bessara Nuntapinit; Anais Valencia-Micolta; Doris Thelian; Sorachai Nitayaphan; Punnee Pitisuttithum; Robert M. Paris; Jaranit Kaewkungwal; Nelson L. Michael; Supachai Rerks-Ngarm; Bonnie Mathieson; Mary Marovich; Jeffrey R. Currier; Jerome H. Kim; Supamit Chunsuttiwat; Nakorn Premsri; Chawetsan Namwat; Prayura Kunasol; Prasert Thongcharoen; Chirasak Khamboonruang; Valai Bussaratid; Wirach Maek-a-nantawat; Jittima Dhitavat; Pravan Suntharasamai; Swangjai Pungpak; Siriwan Vanijanonta; Jaranit Kaewkunwal; Amnat Khamsiriwatchara; Pawinee Jarujareet; Chirapa Easmila; Suchana Tabprasit; Viseth Ngauy; Robert Paris; Michael Benenson; Patricia Morgan; Arthur Brown; Mark De Souza; Rapee Trichavaroj; Nusara Thaitawat; Kanyasiri Kongnonkok; Boot Keawboon; Yuwadee Phuang-Ngern; Susan Mason; Sanjay Gurunathan; Jim Tartaglia; John G. McNeil; Robin Harkness; Claude Meric; Lynn Baglyos; Raphaelle El Habib; Don Francis; Carter Lee; Elizabeth Adams; Merlin L. Robb; Mark Milazzo; Amy Bolen; Beryl Wessner; Jeffrey Currier; Deborah L. Birx; Don Stablein; Terry Germanson; Len Dally; Jean Louis Excler; Jeffrey Berenberg; Armed Forces Research Institute of Medical Sciences, Thailand; Walter Reed Army Institute of Research; Mahidol University; Thailand Ministry of Public Health; National Institutes of Health, Bethesda; Sanofi Pasteur; Sanofi Pasteur; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; U.S. Army Medical Research and Materiel Command; Centers for Disease Control and Prevention; The EMMES Corporation; International AIDS Vaccine Initiative; Tripler Regional Med Center
3-Dec-2009Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in ThailandSupachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark De Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G. McNeil; Donald P. Francis; Donald Stablein; Deborah L. Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L. Robb; Nelson L. Michael; Prayura Kunasol; Jerome H. Kim; Thailand Ministry of Public Health; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; National Institute of Allergy and Infectious Diseases; Sanofi Pasteur; Global Solutions for Infectious Diseases; The EMMES Corporation; Centers for Disease Control and Prevention; Walter Reed Army Institute of Research; US Army Medical Materiel Development Activity